Abiopharma

Net Asset Value(s)

Edgewise Therapeutics - Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)

Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1β Antibody

Best Buy Canada Selects Perion as a Full-Stack Partner to Power its Retail DOOH Media Network

Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial

FORM 6-K- Company Presentation

Mobileye To Establish Vertically Integrated Robotaxi Business

ReposiTrak Traceability Network®, the World’s Largest Food Traceability Network, Surpasses 8.2 Million Supplier Records Collected

NIQ and MRI-Simmons Announce Expansion of Relationship with Cadent to Power Advanced Audience Targeting